表紙
市場調查報告書
商品編碼
1062974

G-CSF(顆粒細胞增生因子)的全球市場(2022年)

G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2022

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 400 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球G-CSF(顆粒細胞增生因子)市場相關調查分析,提供市場特徵,市場趨勢與策略,市場分析,競爭情形等系統性資訊。

目錄

第1章 摘要整理

第2章 G-CSF(顆粒細胞增生因子)市場特徵

第3章 G-CSF(顆粒細胞增生因子)的市場趨勢與策略

第4章 COVID-19對G-CSF(顆粒細胞增生因子)的影響

第5章 G-CSF(顆粒細胞增生因子)的市場規模與成長

  • 全球G-CSF(顆粒細胞增生因子)市場實際成果,10億美元(2016年∼2021年)
    • 推動市場要素
    • 阻礙市場要素
  • 全球G-CSF(顆粒細胞增生因子)市場預測,10億美元(2021年∼2026年)(2031年)
    • 推動市場要素
    • 阻礙市場要素

第6章 G-CSF(顆粒細胞增生因子)市場區隔

  • 全球G-CSF(顆粒細胞增生因子)市場,實際成果及預測,10億美元(2016年∼2021年)(2021年∼2026年)(2031年):各類型
  • 來諾司亭(粒細胞)
  • 非格司亭(Neupogen、Zarzio、Nivestim、Accofil)
  • 長效(聚乙二醇化)非格司亭(pegfilgrastim、Neulasta、Pelmeg、Ziextenco)
  • Lipegfilgrastim (Lonquex)
  • 6.2. 2016-2021、2021-2026F、2031F、10 億美元的全球 G-CSF(粒細胞集落刺激因子)市場、應用細分、歷史和預測
  • 腫瘤疾病
  • 血液疾病
  • 生長激素缺乏症
  • 慢性和自身免疫性疾病
  • 其他
  • 全球G-CSF(顆粒細胞增生因子)市場,實際成果及預測,10億美元(2016年∼2021年)(2021年∼2026年)(2031年):各產品
  • 錠劑
  • 膠囊
  • 其他

第7章 G-CSF(顆粒細胞增生因子)市場地區及國的分析

  • 全球G-CSF(顆粒細胞增生因子)市場,實際成果及預測,10億美元(2016年∼2021年)(2021年∼2026年)(2031年):各地區
  • 全球G-CSF(顆粒細胞增生因子)市場,實際成果及預測,10億美元(2016年∼2021年)(2021年∼2026年)(2031年):各國

第8章 亞太地區的G-CSF(顆粒細胞增生因子)市場

第9章 中國的G-CSF(顆粒細胞增生因子)市場

第10章 印度的G-CSF(顆粒細胞增生因子)市場

第11章 日本的G-CSF(顆粒細胞增生因子)市場

第12章 澳洲的G-CSF(顆粒細胞增生因子)市場

第13章 印尼的G-CSF(顆粒細胞增生因子)市場

第14章 韓國的G-CSF(顆粒細胞增生因子)市場

第15章 西歐的G-CSF(顆粒細胞增生因子)市場

第16章 英國的G-CSF(顆粒細胞增生因子)市場

第17章 德國的G-CSF(顆粒細胞增生因子)市場

第18章 法國的G-CSF(顆粒細胞增生因子)市場

第19章 東歐的G-CSF(顆粒細胞增生因子)市場

第20章 俄羅斯的G-CSF(顆粒細胞增生因子)市場

第21章 北美的G-CSF(顆粒細胞增生因子)市場

第22章 美國的G-CSF(顆粒細胞增生因子)市場

第23章 南美的G-CSF(顆粒細胞增生因子)市場

第24章 巴西的G-CSF(顆粒細胞增生因子)市場

第25章 中東的G-CSF(顆粒細胞增生因子)市場

第26章 非洲的G-CSF(顆粒細胞增生因子)市場

第27章 G-CSF(顆粒細胞增生因子)市場競爭情形和企業簡介概要

  • G-CSF(顆粒細胞增生因子)市場競爭情形
  • G-CSF(顆粒細胞增生因子)市場企業簡介概要
    • BioCad
    • Teva Pharmaceuticals
    • Pfizer
    • Intas Pharmaceuticals
    • Novartis AG

第28章 G-CSF(顆粒細胞增生因子)開發平台分析

第29章 G-CSF(顆粒細胞增生因子)市場上主要合併和收購

第30章 G-CSF(顆粒細胞增生因子)市場未來展望與潛在性分析

第31章 附錄

目錄
Product Code: h1196

“G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global g-csf (granolocyte colony stimulating factors) market.

This report focuses on g-csf (granolocyte colony stimulating factors) market which is experiencing strong growth. The report gives a guide to the g-csf (granolocyte colony stimulating factors) market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the g-csf (granolocyte colony stimulating factors)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The G-CSF (Granolocyte Colony Stimulating Factors) market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider g-csf (granolocyte colony stimulating factors) market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The g-csf (granolocyte colony stimulating factors) market section of the report gives context. It compares the g-csf (granolocyte colony stimulating factors) market with other segments of the g-csf (granolocyte colony stimulating factors) market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, g-csf (granolocyte colony stimulating factors) indicators comparison.

Scope

Markets Covered:

1) By Type: Lenograstim (Granocyte); Filgrastim (Neupogen, Zarzio, Nivestim, Accofil); Long Acting (Pegylated) Filgrastim (Pegfilgrastim, Neulasta, Pelmeg, Ziextenco); Lipegfilgrastim (Lonquex)

2) By Application: Oncological Diseases; Blood Disorders; Growth Hormone Deficiencies; Chronic And Autoimmune Disorders; Others

3) By Product: Tablet; Capsule; Others

Companies Mentioned: BioCad; Teva Pharmaceuticals; Pfizer; Intas Pharmaceuticals; Novartis AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. G-CSF (Granulocyte Colony Stimutating Factors) Market Characteristics

3. G-CSF (Granulocyte Colony Stimutating Factors) Market Trends And Strategies

4. Impact Of COVID-19 On G-CSF (Granulocyte Colony Stimutating Factors)

5. G-CSF (Granulocyte Colony Stimutating Factors) Market Size And Growth

  • 5.1. Global G-CSF (Granulocyte Colony Stimutating Factors) Historic Market, 2016-2021, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global G-CSF (Granulocyte Colony Stimutating Factors) Forecast Market, 2021-2026F, 2031F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. G-CSF (Granulocyte Colony Stimutating Factors) Market Segmentation

  • 6.1. Global G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Lenograstim (Granocyte)
  • Filgrastim (Neupogen, Zarzio, Nivestim, Accofil)
  • Long acting (pegylated) filgrastim (pegfilgrastim, Neulasta, Pelmeg, Ziextenco)
  • Lipegfilgrastim (Lonquex)
  • 6.2. Global G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oncological Diseases
  • Blood Disorders
  • Growth Hormone Deficiencies
  • Chronic and Autoimmune Disorders
  • Others
  • 6.3. Global G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Tablet
  • Capsule
  • Others

7. G-CSF (Granulocyte Colony Stimutating Factors) Market Regional And Country Analysis

  • 7.1. Global G-CSF (Granulocyte Colony Stimutating Factors) Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 7.2. Global G-CSF (Granulocyte Colony Stimutating Factors) Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 8.1. Asia-Pacific G-CSF (Granulocyte Colony Stimutating Factors) Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 8.3. Asia-Pacific G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 9.1. China G-CSF (Granulocyte Colony Stimutating Factors) Market Overview
  • 9.2. China G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
  • 9.3. China G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 10.1. India G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 10.2. India G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 11.1. Japan G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 11.2. Japan G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 12.1. Australia G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 12.2. Australia G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 13.1. Indonesia G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 13.2. Indonesia G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 14.1. South Korea G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 14.2. South Korea G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 15.1. Western Europe G-CSF (Granulocyte Colony Stimutating Factors) Market Overview
  • 15.2. Western Europe G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 15.3. Western Europe G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 16.1. UK G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 16.2. UK G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 17.1. Germany G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 17.2. Germany G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 18.4. France G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 18.5. France G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 19.1. Eastern Europe G-CSF (Granulocyte Colony Stimutating Factors) Market Overview
  • 19.2. Eastern Europe G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 19.3. Eastern Europe G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 20.1. Russia G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 20.2. Russia G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 21.1. North America G-CSF (Granulocyte Colony Stimutating Factors) Market Overview
  • 21.2. North America G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 21.3. North America G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 22.1. USA G-CSF (Granulocyte Colony Stimutating Factors) Market Overview
  • 22.2. USA G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 22.3. USA G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 23.1. South America G-CSF (Granulocyte Colony Stimutating Factors) Market Overview
  • 23.2. South America G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 23.3. South America G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 24.1. Brazil G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 24.2. Brazil G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 25.1. Middle East G-CSF (Granulocyte Colony Stimutating Factors) Market Overview
  • 25.2. Middle East G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 25.3. Middle East G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa G-CSF (Granulocyte Colony Stimutating Factors) Market

  • 26.1. Africa G-CSF (Granulocyte Colony Stimutating Factors) Market Overview
  • 26.2. Africa G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 26.3. Africa G-CSF (Granulocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. G-CSF (Granulocyte Colony Stimutating Factors) Market Competitive Landscape And Company Profiles

  • 27.1. G-CSF (Granulocyte Colony Stimutating Factors) Market Competitive Landscape
  • 27.2. G-CSF (Granulocyte Colony Stimutating Factors) Market Company Profiles
    • 27.2.1. BioCad
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Teva Pharmaceuticals
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Pfizer
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Intas Pharmaceuticals
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Novartis AG
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. G-CSF (Granulocyte Colony Stimutating Factors) Pipeline Analysis

29. Key Mergers And Acquisitions In The G-CSF (Granulocyte Colony Stimutating Factors) Market

30. G-CSF (Granulocyte Colony Stimutating Factors) Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer